iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
Naiqing Ding(Nanjing Drum Tower Hospital), Baorui Liu(Nanjing University of Chinese Medicine)
Cited by 125
Related Papers
Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy
|Nature Communications|2022|102
Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy
|Oncology Reports|2017|42
Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells
|International Journal of Nanomedicine|2014|37
sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
|Scientific Reports|2017|21